SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Unichem Laboratories turns black in Q2

02 Nov 2020 Evaluate

Unichem Laboratories has reported results for second quarter ended September 30, 2020.

The company has reported net profit of Rs 30.34 crore for the quarter under review as against net loss of Rs 24.86 crore for the same quarter in the previous year. Total income of the company increased 26.44% at Rs 321.34 crore for Q2FY21 as compared Rs 254.15 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported net profit at Rs 8.74 crore for the quarter under review as against net loss of Rs 22.21 crore for the same quarter in the previous year. Total income of the company increased by 10.56% at Rs 327.55 crore for Q2FY21 as compared Rs 296.27 crore for the corresponding quarter previous year.

Unichem Laboratories Share Price

461.35 7.95 (1.75%)
30-Jun-2026 13:11 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1868.90
Dr. Reddys Labs. 1365.15
Cipla 1468.70
Zydus Lifesciences 1123.65
Lupin 2410.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: